Meshach Rhoades Named to 5280 Magazine’s Denver’s Top Lawyers 2023 List
Firm News | 1 min read | 01.12.23
Denver – January 12, 2023: 5280 Magazine has named Meshach Y. Rhoades, managing partner of Crowell & Moring’s Denver office, to its 2023 list of Denver’s Top Lawyers in the Commercial Litigation category. The ninth annual list features the best attorneys in the region, based on recommendations from peers and follow-up reporting.
Rhoades is a partner in Crowell’s Litigation Group. She represents clients whose groundbreaking products and services raise novel questions with regulators, consumers and competitors. She has significant experience in the food and beverage, technology, telecom, and finance sectors, handling high-stakes class action litigation, investigations, and complex commercial cases. Rhoades frequently advises clients on compliance, litigation, and enforcement matters involving the Food and Drug Administration, the Federal Trade Commission, the Department of Agriculture and other U.S. regulatory bodies, as well as European Union regulators.
To learn more about the feature and view the list of Top Lawyers, please click here.
About Crowell & Moring LLP
Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues. The firm is consistently recognized for its commitment to pro bono service and its programs and initiatives to advance diversity, equity and inclusion.
Insights
Firm News | 1 min read | 03.11.25
Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo
March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
Firm News | 2 min read | 03.11.25
Daily Journal Honors Crowell & Moring Victory in University of California Case
Firm News | 2 min read | 03.11.25
Foreign Investment Watch Names Caroline Brown a Top Advisor 2025
Firm News | 2 min read | 03.07.25
Crowell & Moring Attorneys Honored With 2025 Burton Award for Distinguished Legal Writing